Try our Advanced Search for more refined results
December 10, 2008
Track this case
Paul A. Magnuson
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.Additional or older documents may be available in Pacer.
Medtronic Inc. has agreed to pay shareholders $85 million to settle a class action in Minnesota federal court alleging the medical device maker lied to investors about off-label marketing of its Infuse spinal graft system, the company said Friday.
Already a subscriber? Click here to login